Evaluation of the Effects of 50 Hz Magnetic Field Exposure on the Human Hematopoietic System in Humanized Mice Authors: Masayuki Takahashi, Izumi Nishimura, Toshihiko Toda Published: 2026 ABSTRACT ABSTRACTAccumulating evidence from experimental animal studies is essential for clarifying the causal relationship between exposure to power‐frequency magnetic fields (MFs) and childhood leukemia. In this study, we developed a 50 Hz MF exposure system for experimental animals. To ensure uniform whole‐body exposure of multiple animals placed at the center of the coil, we fabricated a Merritt‐type coil. The maximum MF output inside the coil was 5 mT(rms), and spatial variation remained within ±2.5% of the target intensity. The system enabled stable exposure of experimental animals to uniform 50 Hz MFs while eliminating equipment‐related artifacts. We then conducted exposure experiments using humanized mice, in which a human‐like hematopoietic system was established by transplanting human hematopoietic stem and progenitor cells (HSPCs), to a 50 Hz, 5 mT(rms) MF for 2 months. After exposure, the chimerism rates of human leukocytes in hematopoietic organs of the MF‐exposed group were comparable to those in the control group. Furthermore, exposure to the 50 Hz MF did not affect early differentiation of human B cells in the bone marrow of humanized mice. These findings support our previous in vitro results and validate the use of humanized mice for evaluating the effects of power‐frequency MFs on human hematopoiesis. This system is expected to evaluate the effects of 50 Hz MFs not only on normal human hematopoiesis in humanized mice but also under abnormal conditions such as preleukemic state induced by transplanting genetically modified HSPCs.Keywords: childhood leukemia, extremely low‐frequency magnetic field, human hematopoietic system, humanized mice Introduction An epidemiological study first suggested a possible association between exposure to power‐frequency magnetic fields (MFs) and the development of childhood leukemia in 1979 (Wertheimer and Leeper 1979). Since then, evidence has accumulated, particularly through regularly published, meaningful results from pooled analyses (Ahlbom et al. 2000; Kheifets et al. 2010; Amoon et al. 2022). Notably, this association has weakened over time (Pedersen et al. 2015; Bunch et al. 2016; Swanson et al. 2019). However, concluding a substantial relationship between exposure to power‐frequency MFs and the development of childhood leukemia based solely on epidemiological evidence remains a challenge. Given the low incidence of childhood leukemia and the rarity of residential environments with high levels of power‐frequency MFs, epidemiological studies face considerable challenge in ruling out confounding factors and selection bias. The most recent opinion on the health risk of extremely low‐frequency (ELF) electromagnetic fields (EMFs) published in 2024 by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) recommends evaluations using appropriate animal models for acute lymphoblastic leukemia and in vitro hypothesis‐driven studies to elucidate the potential interaction mechanisms of ELF‐EMF (SCHEER 2024). B‐cell progenitor acute lymphoblastic leukemia (B‐ALL) is the most common type of childhood leukemia (Mullighan 2012). During the basic B‐cell differentiation process, hematopoietic stem cells in the bone marrow (BM) differentiate into common lymphoid progenitors, which then commit to the B‐cell lineage. This differentiation progresses through pre‐pro‐B, pro‐B, and pre‐B cell stages, ultimately giving rise to immature B cells. These immature B cells then migrate to secondary lymphoid organs, such as the spleen (SP), where they mature into antibody‐producing cells. B‐ALL is typically caused by the malignant transformation of cells at the pro‐B or pre‐B cell stage, during which they acquire abnormal differentiation and proliferation abilities within the BM (Greaves 2018). Thus, to determine whether MF exposure is related to leukemogenesis, animal models should be characterized by a predisposition to leukemogenesis at the pro‐B and/or pre‐B cell stage within the BM. In the ARIMMORA project (Schüz et al. 2016), a transgenic mouse harboring ETV6‐RUNX1, a translocation gene most frequently detected in childhood leukemia (Pui et al. 2011), was developed as a B‐ALL model. A pilot study using this model was conducted to evaluate the effects of MF exposure (Campos‐Sanchez et al. 2019). Moreover, to investigate the potential mechanisms by which MF exposure may influence leukemogenesis, it is crucial to conduct in vitro/vivo evaluations focusing on B‐cell differentiation and/or pro‐B and pre‐B cells in the BM. This is because both the cell type and differentiation stage could influence cellular functions, sensitivity, and the expression of related genes and proteins. We established in vitro models of differentiation to the B‐cell lineage in the BM using human induced pluripotent stem (iPS) cells and human primary cells and evaluated the effects of MF exposure on the process (Takahashi and Furuya 2022, 2023). Although a lot of studies have reported the biological effects of power‐requency MFs as scientific evidence associated with leukemogenesis, the number of scientific reports based on a similar concept is limited, and actually, the accumulation of scientific findings is insufficient. In the current study, we propose an in vivo evaluation method using humanized mice as a new platform to evaluate the effects of MF exposure on the human hematopoietic system. Humanized mice, established through the transplantation of human cells into immunodeficient murine hosts, are widely recognized as valuable in vivo models for partially recapitulating human cell–cell and cell–tissue interactions. These models enable the investigation of human cellular behavior, functionality, and responsiveness in vivo, thereby providing critical insights into human physiology and disease mechanisms (Allen et al. 2019; Luo et al. 2022; Celhar et al. 2024; Chupp et al. 2024). In humanized mice engrafted with human CD34+ hematopoietic stem and progenitor cells (HSPCs), a human‐like hematopoietic system was constructed and stably maintained over an extended period (Takahashi, Tsujimura, Otsuka, et al. 2012). We previously demonstrated that the hematotoxic responses observed in humanized mice closely resemble those observed in humans and that humanized mice can be effectively utilized to analyze human hematotoxicity in vivo (Takahashi, Tsujimura, Yoshino, et al. 2012). In this study, we developed an MF exposure system that enables the stable and continuous exposure of experimental animals to high‐intensity power‐frequency MFs. Using this system, we performed 2‐month exposure tests on humanized mice to evaluate the effects of MF exposure on B‐cell differentiation in the BM. Materials and Methods Cells and Mice Human CD34+ cells isolated from cord blood were purchased from Lonza (Lots: 22TL066882, 22TL238355, and 23TL303889; Basel, Switzerland) and cryopreserved in liquid nitrogen prior to use. Severely immunodeficient NOD.Cg‐PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice (4‐week‐old, male) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed in specific pathogen‐free conditions under a 12‐h light/dark cycle and appropriate air conditioning. Sterile food and water were provided ad libitum. All animal experimental protocols were approved by the Ethics Committee for Research and Welfare of Experimental Animals of the Central Research Institute of Electric Power Industry. MF Exposure System An MF exposure system was designed and manufactured with Techno Electric Industry (Kanagawa, Japan). To uniformly expose the animals, we fabricated a Merritt‐type coil (Figure 1). Four rectangular coils of 820 × 820 mm were stacked vertically to generate an MF with a synthetic vector in the vertical direction. The coil‐winding ratio was 26:11:11:26 (52, 22, 22, and 52 turns) from top to bottom, and each coil was connected in a series. Coils were made of hollow copper wires, and cooling water was circulated through the coils. Two‐tiered breeding shelves for the animals were installed at the center of the coils. The vibrations from the coils were eliminated by installing the shelves on an independent platform from the coils. The two shelves provided space for up to eight commercially available mouse cages for group breeding. A high‐performance multifunctional AC Power Supply (PCR4000LES; Kikusui Electronics Industry, Yokohama, Japan) was used as the power supply for the coils. The 50 Hz sinusoidal signal output from the power supply was boosted by a transformer and sent to the coils via a resonant capacitor. The current immediately after the capacitor was monitored using a current sensor (DS200UB‐10V; DANISENSE, Taastrup, Denmark) and fed back to the power supply for constant current control. Photograph of the fabricated magnetic field (MF) exposure system for experimental animals. A 50 Hz sinusoidal MF was generated vertically at a maximum intensity of 5 mT(rms). To prevent disruption of the generated MF, most components, except for the coils, were made of non‐conductive materials such as wood. Experimental animals were housed in polymethylpentene cages, which were arranged on two wooden shelves positioned at the center of the coils. After installing the coils and power supply, an isotropic MF probe (ELT‐400; Narda Safety Test Solutions, Pfullingen, Germany), sensor units with a current sensor (CT9556 or CT6873‐01; HIOKI, Nagano, Japan), and a data logger (NR600; KEYENCE, Osaka, Japan) were used to clarify the association between the current value and the magnetic flux density. The magnetic flux density in the mouse breeding space was measured in three axial directions at intervals of 25–100 mm from the center of each breeding shelf using a three‐axis teslameter (F71; Lake Shore Cryotronics, Westerville, OH, USA). The breeding space temperature was measured by using a data logger equipped with a temperature sensor (TR‐52i; T&D Corporation, Nagano, Japan). Cell Transplantation into NSG Mice After a week of acclimatization, NSG mice (25 mg/kg weight) received intraperitoneal busulfan (Sigma‐Aldrich, St. Louis, MO, USA) injections twice, approximately 48‐ and 24‐h prior to cell transplantation. Human CD34+ cells suspended in IMDM (200 μL containing 4 × 104 cells/mouse) were injected intravenously into the mice via the tail vein. Mouse Grouping and MF Exposure Two months after cell transplantation, we collected peripheral blood (PB) from the tail vein of the mice and analyzed the percentage of human and mouse leukocytes. Briefly, peripheral blood pretreated with Human BD Fc Block (BD Biosciences, Franklin Lakes, NJ, USA) was stained with Alexa Fluor 488‐conjugated anti‐mouse CD45 (clone 30‐F11; BioLegend, San Diego, CA, USA) and R718‐conjugated anti‐human CD45 (clone HI30; BD Biosciences) antibodies. Flow cytometric analysis was performed using a FACSAria III (BD Biosciences) following hemolysis with VersaLyse Lysing Solution (Beckman Coulter, Brea, CA, USA). Flow cytometry data were analyzed using Kaluza software (Beckman Coulter). We then calculated the chimerism rate as the percentage of human CD45+ leukocytes in the total leukocyte population (the sum of mouse CD45+ and human CD45+ leukocytes) and the mice were grouped based on the chimerism rate. After grouping, the MF‐exposed or sham‐exposed groups were placed in the constructed coils, and the negative control and lipopolysaccharide (LPS; Sigma‐Aldrich)‐treated (positive control) groups were placed in a separate animal facility with similar air, lighting, and other conditions. The MF‐exposed group was continuously exposed to 50 Hz, 5 mT(rms) MFs for 2 months, except for an hour of animal care per day, twice a week. In the LPS‐treated group, LPS was intraperitoneally administered once a week (1 µg/mouse). Polymethylpentene mouse cages (Tokiwa, Tokyo, Japan), polycarbonate cage tops (Sibata Scientific Technology, Saitama, Japan), polysulfone water bottles (Tokiwa), and butyl rubber lids with glass mouthpieces (Natsume Seisakusho, Tokyo, Japan) were used in all the groups. The positions of the animal cages on the breeding shelves inside the coils were rotated weekly to equalize the subtle differences in environmental conditions and MF intensity. Analysis of Tissue Cells After MF exposure, hematopoietic cells from the PB, SP, and femur BM were prepared from each mouse. Hematopoietic cells from PB were collected as described above. Cells in the SP or BM were collected by crushing between two glass slides or by excising and crushing the epiphysis and metaphysis using a mortar and by pushing a needle through the diaphysis. After pretreatment with Human BD Fc Block, the cells were stained with Alexa Fluor 488‐conjugated anti‐mouse CD45, R718‐conjugated anti‐human CD45, APC/Fire 750‐conjugated anti‐human CD10 (clone HI10a; BioLegend), BV421‐conjugated anti‐human CD19 (clone HIB19; BD Biosciences), BV510‐conjugated anti‐human IgM (clone G20‐127; BD Biosciences), and BV711‐conjugated anti‐human CD33 (clone WM53; BD Biosciences) antibodies. Following the hemolysis procedure, the cells were analyzed using a FACSAria III and Kaluza software. Nonspecific signals and dead cells were excluded using appropriate fluorochrome‐conjugated isotype and 7‐AAD (BioLegend) staining, respectively. To ensure a strictly blinded experimental design, different technicians were assigned to expose the mice to MFs and to perform flow cytometric analyses using coded samples, thereby minimizing bias during manual gating. Statistical Analysis Statistical analysis was performed using one‐way analysis of variance (ANOVA) with Igor Pro software (WaveMetrics, Portland, OR, USA). Results were considered statistically significant at p < 0.05. Results Performance of MF Exposure System We assessed the performance of the newly fabricated MF exposure system (Figure 1). A 50 Hz sinusoidal MF of 5 mT(rms), which is over 10,000 times the epidemiologically suggested threshold for an increased risk of childhood leukemia (0.4 µT) (Ahlbom et al. 2000), was generated by applying a 48.7 A(rms) current from an AC‐stabilized power supply. The current remained constant within ±0.1 A(rms) during 2 months of continuous operation (Figure 2A), which indicates the capability of our exposure system to generate a constant MF. The magnetic flux density was measured in three axial directions at intervals of 25–100 mm from the center of each breeding shelf. The uniformity of the flux density was over 95% in a rectangular space of 500 × 500 × 150 mm (L × D × H), where eight mouse cages for group breeding could be placed (Figure S1). No temperature increase in the breeding space was observed during coil energization (Figure 2B). These results show that up to 40 mice can be simultaneously exposed to a maximum of 5 mT(rms), uniform 50 Hz MF continuously, without artificial heat radiation from the energized coils by using this MF exposure system. Long‐term stability of exposure conditions using the magnetic field (MF) exposure system. (A) Coil current during the 2‐month 5 mT(rms) MF exposure test. The upper panel shows the full‐scale data of the 2‐month exposure test, and the lower panel presents a close‐up of a partial time during a day. Measurements of the current were recorded at intervals of 60–90 s throughout the test. A 5 mT(rms) MF was generated by a 48.7 A(rms) electric current. An open arrowhead indicates the initiation, and a closed arrowhead indicates the termination of the exposure test. The current was temporarily turned off at points marked with asterisks (*) for routine animal care. (B) Temperature profile of the breeding space inside the coils during and after MF exposure. The room temperature was maintained at 22°C–23°C. Effects of MF on Human Hematopoiesis in Humanized Mice Next, we performed MF exposure tests using human CD34+ HSPC‐engrafted humanized mice and the newly fabricated MF exposure system (Figure 3A). To evaluate the effects of MF on human hematopoiesis, each mouse group was ensured to have an equal chimerism rate of human leukocytes. We grouped mice 2 months after cell transplantation, when human leukocytes reliably appeared in the PB, and the final analysis was performed 4 months after cell transplantation, when human hematopoiesis was maintained within humanized mice (Takahashi, Tsujimura, Otsuka, et al. 2012). Before the MF‐exposure tests, a sham‐exposure test was performed using unenergized coils. The chimerism rates in the BM, SP, and PB of the sham‐exposed group were comparable to those in the control group (Figure 3C). It was verified that no factors affecting human hematopoiesis in humanized mice occurred in the experimental environment and that it was possible to evaluate the effects of MF exposure. Magnetic field (MF) exposure tests using human CD34+ HSPC‐engrafted humanized mice and fabricated MF exposure system. (A) Schematic representation of MF exposure protocol. (B) Flow cytometry. Following gating of 7‐AAD⁻ viable cells, human (hCD45⁺) and mouse (mCD45⁺) leukocyte populations were distinguished. hCD33 and hCD19 expression levels were analyzed within hCD45⁺mCD45⁻ human leukocyte population. hCD24 and hIgM expressions were analyzed in hCD19⁺hCD33⁻ B‐cell lineage. (C) Chimerism rates in BM, SP, and PB of humanized mice after sham exposure. Chimerism rates were compared between control and sham‐exposed groups, which were maintained inside unpowered coils. Bars represent mean (n = 7 mice per group). Statistical significance was determined using one‐way ANOVA. During the 2 months of exposure tests with 50 Hz, 5 mT(rms) MFs, the exposed mice grew normally, and no abnormal behaviors were observed, as in the control mice. Although the chimerism rates in all analyzed tissues of the LPS‐treated group, which originated from the same batch as the control group, decreased drastically compared to those of the control group, those of the MF‐exposed group were nearly the same (Figure 4B). The chimerism rates of human leukocytes in humanized mice did not change after the 2 months of exposure to 50 Hz, 5 mT(rms) MFs. Similar results were obtained in an independent replicate experiment using different donor‐derived HSPC‐engrafted humanized mice (Figure S2). Effects of 50 Hz, 5 mT(rms) magnetic field (MF) exposure for 2 months on human hematopoiesis in humanized mice. Chimerism rates in bone marrow (BM), spleen (SP), and peripheral blood (PB) of control group were evaluated by flow cytometry and compared to those of MF‐exposed or LPS‐treated groups. Bars represent mean (n = 7 mice per group). Statistical significance was determined using one‐way ANOVA. Effects of MF on B‐Cell Differentiation in BM A detailed analysis of B‐cell lineages in the BM, which represent malignant cells in most childhood leukemia cases, was performed. The results of the two independent experiments are listed in Table 1. Compared to the control group, the MF‐exposed group exhibited a similar differentiation bias between hCD19⁺hCD33⁻ B‐cell lineages and hCD33⁺hCD19⁻ myeloid cells. Furthermore, analysis of cell surface IgM expression during the differentiation of pro‐ and pre‐B cells (IgM−) to immature B cells (IgM+) revealed no significant differences between the two groups. These findings were reproducible across all the experiments. Table 1Effects of 50 Hz, 5 mT(rms) magnetic field (MF) exposure for 2 months on human B‐cell differentiation in the BM of humanized mice.CellTrial% in hCD45(+)mCD45(−) p‐valueAverageSDhCD19(+)#15 mT84.72.660.220 mT86.52.61hCD33(‐)#25 mT79.14.140.720 mT78.43.66hCD33(+)#15 mT9.461.820.300 mT8.441.66hCD19(‐)#25 mT15.52.480.720 mT16.02.83CellTrial % in hCD45(+)mCD45(−) hCD19(+)hCD33(−) p‐valueAverageSDhCD24(+)#15 mT82.30.960.060 mT83.81.59hIgM(‐)#25 mT75.91.830.580 mT76.62.64hCD24(+)#15 mT15.00.820.130 mT14.01.44hIgM(+)#25 mT21.22.000.780 mT20.92.02 Note: Rates of hCD33⁺hCD19⁻ myeloid cells or hCD19⁺hCD33⁻ B‐cell lineage‐committed cells within human leukocyte populations were evaluated by flow cytometry. Rates of hCD24⁺hIgM− pro‐/pre‐B cells or hCD24⁺hIgM+ immature B cells within the B‐cell lineage were evaluated. Rates were statistically compared between the control (0 mT) and the MF‐exposed (5 mT) groups using one‐way ANOVA. Two trials were completely independent, and data were acquired from different sets of control and MF‐exposed groups in each trial (n = 7 mice per group). Effects of 50 Hz, 5 mT(rms) magnetic field (MF) exposure for 2 months on human B‐cell differentiation in the BM of humanized mice. Note: Rates of hCD33⁺hCD19⁻ myeloid cells or hCD19⁺hCD33⁻ B‐cell lineage‐committed cells within human leukocyte populations were evaluated by flow cytometry. Rates of hCD24⁺hIgM− pro‐/pre‐B cells or hCD24⁺hIgM+ immature B cells within the B‐cell lineage were evaluated. Rates were statistically compared between the control (0 mT) and the MF‐exposed (5 mT) groups using one‐way ANOVA. Two trials were completely independent, and data were acquired from different sets of control and MF‐exposed groups in each trial (n = 7 mice per group). Discussion A fundamental distinction between MFs and chemical compounds in evaluating biological effects is that MFs require a dedicated exposure system. The performance of an MF exposure system is critical, as it directly influences both the quantity and quality of exposure, which in turn affects the reliability of the study. Researchers must ensure the proper performance of their MF exposure system, and readers should pay equal attention to the specifications of the system as to the study's results. In alignment with the World Health Organization (WHO)'s agenda for electromagnetic research (WHO 1998), we developed an MF exposure system based on three key concepts: (1) it can continuously and stably generate strong MFs; (2) it enables the simultaneous exposure of multiple experimental animals to highly uniform MFs; and (3) it effectively eliminates secondary factors that could potentially influence the experimental outcomes. Our MF exposure system was designed to generate a maximum intensity of 5 mT(rms), which is over 10,000 times higher than the epidemiologically suggested threshold of 0.4 µT for an increased risk of childhood leukemia (Ahlbom et al. 2000). Based on dosimetry analysis (Gong et al. 2016), the internal electric field induced in a mouse by 5 mT MF exposure is approximately three times higher than that induced in a child by a MF at the ICNIRP limit (200 µT). The power supply was operated under constant‐current control to ensure stable MF over the time of exposure tests. The uniformity of the generated MFs by the Merritt‐type coil was confirmed by measuring the MF at 648 points in the animal exposure space. A maximum of eight mouse cages, accommodating up to 40 mice in total, could be placed in the highly uniform MFs, where the strength is maintained within ±2.5% of the target intensity. Regarding potential factors from the coil that may influence the experimental animals, heat radiation was effectively suppressed by circulating cooling water through hollow copper wires. The vibrations originating from the coils were considered negligible because the breeding shelves were structurally isolated from the coils. To ensure experimental accuracy, the coil current, temperature of the circulating cooling water, and temperature and humidity of the MF exposure space were monitored continuously throughout the experiments. As our exposure system is sufficient in MF intensity, spatial uniformity, and stability over the long exposure period, it can contribute to obtaining highly reliable biological results. To the best of our knowledge, this system represents one of the highest‐performance MF exposure systems previously published for evaluating the biological effects of power‐frequency MFs on experimental animals. Previously reported large‐scale exposure experiments in rodents have used 50 Hz MFs at maximum levels of 1.0–1.5 mT (Soffritti et al. 2016a; 2016b; Bua et al. 2018; Campos‐Sanchez et al. 2019). In the present study, we used human CD34+ HSPC‐engrafted humanized mice to evaluate the effects of power‐frequency MFs on the human hematopoietic system. To take advantage of in vivo evaluation, we assessed the alterations caused by MF exposure in hematopoiesis originating from engrafted human HSPCs in the BM, as well as in other hematopoietic organs. We specifically focused on B‐cell differentiation, which is closely associated with leukemogenesis. The results indicated that human leukocyte production from HSPCs in the BM and their migration to the SP and PB in the MF‐exposed group were comparable to those in the control group. Even when exposed to an MF substantially stronger than 0.4 μT, an exposure level reported by epidemiological studies to increase the risk of childhood leukemia, it did not induce any changes associated with leukemia induction in humanized mice. The production of human leukocytes in humanized mice was disturbed by repeated immune stimulation using LPS, a potent immunogen. The delayed infection hypothesis (Greaves 1988) suggests that an abnormal immune response may contribute to the development of childhood leukemia, which has been supported by numerous epidemiological studies (Dockerty et al. 2001; Gilham et al. 2005; Marcotte et al. 2016). The results of the current study indicate that continuous exposure to 50 Hz, 5 mT(rms) MFs does not elicit an immune response sufficient to affect human leukocyte production in humanized mice, in contrast to the effects observed with repeated LPS administration. We previously reported that exposure to 50 Hz MF at 300 mT does not affect B‐cell early differentiation from human CD34+ HSPCs, based on results obtained using an in vitro differentiation protocol (Takahashi and Furuya 2023). The findings of the current study reinforce our previous understanding and provide additional in vivo evidence. This consistency of the findings validates the utilization of human CD34+ HSPC‐engrafted humanized mice in evaluations of the effects of power‐frequency MFs on human hematopoiesis. However, it should be noted that human hematopoiesis in humanized mice occurs within a bone marrow microenvironment composed of mouse cells; consequently, cellular interactions and cytokine‐mediated signals may differ from those in the human body. In this study, we completed an exposure period of 4 months after cell transplantation because previous findings have indicated that human hematopoiesis is maintained with certainty and stability in humanized mice. Our preliminary investigations demonstrated that human hematopoiesis can be maintained stably over extended periods in humanized mice and that it would be possible to apply humanized mice to longer‐term MF exposure tests. We evaluated the feasibility of using human CD34+ HSPC‐engrafted humanized mice to investigate the interaction mechanisms between MF exposure and leukemogenesis rather than utilizing them as an animal model for evaluating MF‐induced leukemogenesis. This approach was considered because the actual incidence rate of childhood leukemia suggests that an impractically large number of humanized mice constructed with commercially available human CD34+ HSPCs from healthy donors would be required to observe leukemogenesis in humanized mice. If human HSPCs harboring a B‐ALL‐specific translocation gene can be used as donor cells for the construction of humanized mice, these preleukemic mice may serve as a viable animal model for evaluating leukemogenesis, similar to the transgenic mice in the ARIMMORA project (Rodríguez‐Hernández et al. 2017). Genetically modified human HSPCs can be obtained either from rare volunteers or by artificial gene transfer into normal HSPCs. However, individuals carrying HSPCs with a translocation gene without additional gene mutations are typically healthy. Protocols for long‐term maintenance and expansion of transplantable human HSPCs, which are necessary for establishing a cell line harboring a translocation gene, remain under development (Sakurai et al. 2023; Suresh et al. 2025). We anticipate an alternative approach using human iPS cell technology and have already constructed two human iPS cell lines harboring a B‐ALL‐specific translocation gene, ETV6‐RUNX1 (Takahashi and Yamazaki 2019) and KMT2A‐AFF1 (Takahashi 2023). The induction of differentiation from genetically modified human iPS cells into transplantable human HSPCs (Piau et al. 2023; Ng et al. 2025) will advance the development of a viable preleukemic humanized mouse model that can contribute to the acquisition of scientific evidence regarding the causal relationship between power‐frequency MF and the development of childhood leukemia. In conclusion, we developed a novel MF exposure system for experimental animals that can stably generate uniform 50 Hz MFs at intensities of up to 5 mT(rms). Using this system, we conducted 2‐month exposure experiments using human CD34+ HSPC‐engrafted humanized mice, in which a human‐like hematopoietic system derived from the transplanted human HSPCs was constructed and maintained over an extended period. The results obtained from humanized mice reinforce our previous in vitro findings, which indicated that exposure to 50 Hz MF does not affect early differentiation of human B cells from HSPCs. These findings also validate the use of humanized mice for evaluating the effects of power‐frequency MFs on human hematopoiesis. We expect that the accumulation of scientific evidence regarding the effects of MFs on human hematopoiesis will be facilitated by the combined use of the developed MF exposure system and human CD34+ HSPC‐engrafted humanized mice. This accumulation of evidence will contribute to concluding the causal relationship between exposure to power‐frequency MFs and the development of childhood leukemia. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Figure S1: Uniformity of magnetic flux density of the breeding space. Magnetic flux density was measured along three axial directions at intervals ranging from 25 mm to 100 mm from the center of each breeding shelf at four heights: 1‐, 51‐, 101‐, and 151‐mm. Open bars represent measuring points within a range ±2.5% of median value of all measurements, while solid bars indicate points outlying the range. No mouse cages were placed on these outlying points. Figure S2: Effects of 50 Hz, 5 mT(rms) magnetic field exposure for 2 months on human hematopoiesis in an independent replicate experiment using different donor‐derived HSPC‐engrafted humanized mice. Bars represent mean (n = 7 mice per group). Statistical significance was determined using one‐way ANOVA. Acknowledgments The authors wish to thank Ms. Chinami Ishiyama (CERES) for her assistance with animal care. We would also like to thank Editage (www.editage.com) for English language editing. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Supplementary Materials Figure S1: Uniformity of magnetic flux density of the breeding space. Magnetic flux density was measured along three axial directions at intervals ranging from 25 mm to 100 mm from the center of each breeding shelf at four heights: 1‐, 51‐, 101‐, and 151‐mm. Open bars represent measuring points within a range ±2.5% of median value of all measurements, while solid bars indicate points outlying the range. No mouse cages were placed on these outlying points. Figure S2: Effects of 50 Hz, 5 mT(rms) magnetic field exposure for 2 months on human hematopoiesis in an independent replicate experiment using different donor‐derived HSPC‐engrafted humanized mice. Bars represent mean (n = 7 mice per group). Statistical significance was determined using one‐way ANOVA. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.